| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |